- Mar 9, 2011
- 70,209
- 84,019
- 3,635
Now we're having a shortage of a medication used to treat asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, acute pneumonia, and acute COVID-19 infections. You can place the blame on three years of wearing those crappy Chinese-made cloth masks, and a presidential administration whose short-sighted policies have destroyed our supply chain.
"The US is already facing a shortage of liquid albuterol used to treat patients with respiratory illnesses like asthma, COPD, chronic bronchitis and acute COVID-19. With a major supplier of the drug to US hospitals shutting down and allergy season around the corner, doctors have all reasons to worry.
Life is only expected to get tougher for those with breathing problems in the United States. Liquid albuterol, which is used to treat patients with respiratory illnesses, has been on the US Food and Drug Administration’s list of drugs in short supply since October. Now the situation is about the get worse.
A major supplier of liquid albuterol to US hospitals has shut down and doctors are worried as this will further impact patients with conditions like asthma...
Akron, a supplier of albuterol, has earlier stopped shipping out the 20-millilitre bottles, the report says. Now, it has shut down its US operations, which include manufacturing facilities in Illinois, New Jersey and New York.
Akron was struggling with bankruptcy for two years and was facing enforcement actions from the FDA. The Illinois factory manufactured liquid albuterol and its shutdown will only add to the shortage.
There is only one remaining domestic supplier of liquid albuterol in the US, supply chain analysts and executives said, according to a report in The Washington Post..."
Albuterol shortage in US: Shortage of medicine to treat asthma, chronic bronchitis explained
"The US is already facing a shortage of liquid albuterol used to treat patients with respiratory illnesses like asthma, COPD, chronic bronchitis and acute COVID-19. With a major supplier of the drug to US hospitals shutting down and allergy season around the corner, doctors have all reasons to worry.
Life is only expected to get tougher for those with breathing problems in the United States. Liquid albuterol, which is used to treat patients with respiratory illnesses, has been on the US Food and Drug Administration’s list of drugs in short supply since October. Now the situation is about the get worse.
A major supplier of liquid albuterol to US hospitals has shut down and doctors are worried as this will further impact patients with conditions like asthma...
Akron, a supplier of albuterol, has earlier stopped shipping out the 20-millilitre bottles, the report says. Now, it has shut down its US operations, which include manufacturing facilities in Illinois, New Jersey and New York.
Akron was struggling with bankruptcy for two years and was facing enforcement actions from the FDA. The Illinois factory manufactured liquid albuterol and its shutdown will only add to the shortage.
There is only one remaining domestic supplier of liquid albuterol in the US, supply chain analysts and executives said, according to a report in The Washington Post..."
Albuterol shortage in US: Shortage of medicine to treat asthma, chronic bronchitis explained